A detailed history of Acadian Asset Management LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,074,375 shares of ORGO stock, worth $9.16 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,074,375
Previous 3,001,679 2.42%
Holding current value
$9.16 Million
Previous $8.52 Million 0.99%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$2.28 - $3.03 $165,746 - $220,268
72,696 Added 2.42%
3,074,375 $8.61 Million
Q1 2024

May 10, 2024

BUY
$2.61 - $4.49 $1.23 Million - $2.12 Million
471,741 Added 18.65%
3,001,679 $8.52 Million
Q4 2023

Feb 13, 2024

SELL
$1.97 - $4.21 $118,802 - $253,888
-60,306 Reduced 2.33%
2,529,938 $10.3 Million
Q3 2023

Nov 13, 2023

BUY
$2.34 - $4.43 $1.28 Million - $2.43 Million
548,175 Added 26.84%
2,590,244 $8.23 Million
Q2 2023

Aug 07, 2023

BUY
$1.9 - $4.3 $1.2 Million - $2.72 Million
633,356 Added 44.96%
2,042,069 $6.78 Million
Q1 2023

May 11, 2023

BUY
$1.89 - $2.93 $414,095 - $641,957
219,098 Added 18.42%
1,408,713 $3 Million
Q4 2022

Feb 14, 2023

BUY
$2.48 - $3.43 $949,386 - $1.31 Million
382,817 Added 47.45%
1,189,615 $3.2 Million
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $2.53 Million - $5.19 Million
806,798 New
806,798 $2.61 Million
Q1 2022

May 12, 2022

SELL
$6.47 - $9.57 $16,822 - $24,882
-2,600 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$9.02 - $13.5 $1.76 Million - $2.64 Million
-195,276 Reduced 98.69%
2,600 $24,000
Q3 2021

Nov 12, 2021

BUY
$13.71 - $17.18 $897,223 - $1.12 Million
65,443 Added 49.42%
197,876 $2.82 Million
Q2 2021

Aug 11, 2021

BUY
$14.92 - $23.23 $1.46 Million - $2.27 Million
97,891 Added 283.4%
132,433 $2.2 Million
Q1 2021

May 11, 2021

BUY
$7.33 - $21.06 $253,192 - $727,454
34,542 New
34,542 $630,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $390M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.